These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1465 related items for PubMed ID: 8851162

  • 1. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS, Cherng CH, Luk HN, Ho ST, Tung CS.
    Eur J Pharmacol; 1996 Feb 15; 297(1-2):27-33. PubMed ID: 8851162
    [Abstract] [Full Text] [Related]

  • 2. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
    Bilsky EJ, Inturrisi CE, Sadée W, Hruby VJ, Porreca F.
    Pain; 1996 Dec 15; 68(2-3):229-37. PubMed ID: 9121809
    [Abstract] [Full Text] [Related]

  • 3. Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord.
    Wong CS, Hsu MM, Chou YY, Tao PL, Tung CS.
    Br J Anaesth; 2000 Oct 15; 85(4):587-91. PubMed ID: 11064618
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats.
    Mao J, Price DD, Lu J, Mayer DJ.
    Neurosci Lett; 1998 Jul 10; 250(3):193-6. PubMed ID: 9708865
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
    Kolesnikov Y, Pasternak GW.
    J Pharmacol Exp Ther; 1999 Jul 10; 290(1):247-52. PubMed ID: 10381783
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
    Chow LH, Huang EY, Ho ST, Lee TY, Tao PL.
    Can J Anaesth; 2004 Nov 10; 51(9):905-10. PubMed ID: 15525615
    [Abstract] [Full Text] [Related]

  • 10. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
    Sakurada T, Watanabe C, Okuda K, Sugiyama A, Moriyama T, Sakurada C, Tan-No K, Sakurada S.
    Brain Res Mol Brain Res; 2002 Jan 31; 98(1-2):111-8. PubMed ID: 11834301
    [Abstract] [Full Text] [Related]

  • 11. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J, Kendig JJ.
    Pain; 1996 Aug 31; 66(2-3):343-9. PubMed ID: 8880858
    [Abstract] [Full Text] [Related]

  • 12. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
    Cao YJ, Bian JT, Bhargava HN.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):161-6. PubMed ID: 9369369
    [Abstract] [Full Text] [Related]

  • 13. N-Methyl-D-aspartate receptor antagonist d-AP5 prevents pertussis toxin-induced alterations in rat spinal cords by inhibiting increase in concentrations of spinal CSF excitatory amino acids and downregulation of glutamate transporters.
    Wong CS, Wu GJ, Chen WF, Jean YH, Hung CH, Lin CS, Huang SY, Wen ZH.
    Brain Res Bull; 2009 Aug 28; 80(1-2):69-74. PubMed ID: 19463918
    [Abstract] [Full Text] [Related]

  • 14. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.
    Haghparast A, Gheitasi IP, Lashgari R.
    Eur J Pain; 2007 Nov 28; 11(8):855-62. PubMed ID: 17291798
    [Abstract] [Full Text] [Related]

  • 15. Increasing of intrathecal CSF excitatory amino acids concentration following morphine challenge in morphine-tolerant rats.
    Wen ZH, Chang YC, Cherng CH, Wang JJ, Tao PL, Wong CS.
    Brain Res; 2004 Jan 09; 995(2):253-9. PubMed ID: 14672815
    [Abstract] [Full Text] [Related]

  • 16. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 09; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 17. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive.
    Ossipov MH, Lopez Y, Nichols ML, Bian D, Porreca F.
    Neurosci Lett; 1995 Oct 20; 199(2):87-90. PubMed ID: 8584250
    [Abstract] [Full Text] [Related]

  • 18. Effect of MK-801 on the antinociceptive effect of [D-Ala(2),N-MePhe(4), Gly-ol(5)]enkephalin in diabetic mice.
    Zushida K, Kamei J.
    Eur J Pharmacol; 2002 Jul 12; 448(1):39-44. PubMed ID: 12126969
    [Abstract] [Full Text] [Related]

  • 19. Differential potentiative effects of glutamate receptor antagonists in the production of antinociception induced by opioids administered intrathecally in the mouse.
    Suh H, Song D, Huh S, Kim YH.
    Brain Res Bull; 2000 May 15; 52(2):143-50. PubMed ID: 10808085
    [Abstract] [Full Text] [Related]

  • 20. Lack of effect of intrathecally administered N-methyl-D-aspartate receptor antagonists in a rat model for postoperative pain.
    Zahn PK, Brennan TJ.
    Anesthesiology; 1998 Jan 15; 88(1):143-56. PubMed ID: 9447867
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 74.